It has been proven that, as maternal age advances, the risk of genetic anomalies in the baby also increases. 

The following graph shows the estimated risk of Down syndrome according to maternal age.

Clarix: the non-invasive prenatal genetic test for detecting chromosomal anomalies

Clarix is a non-invasive Prenatal Genetic Test, which allows you to analyze the genetic health of your baby(s) and know its gender in early stages of pregnancy, from week 10, whether you have conceived spontaneously or with the help of an Assisted Reproduction Treatment.

At Ingenes we choose to use non-invasive methods, such as Clarix, which pose no risk to either the mother or the future baby(s), from a sample of maternal blood (peripheral blood), which contains free DNA from the fetus. This technique has a 99% certainty in the result.

How is Clarix performed?

 For whom is Clarix recommended?

This test is ideal for: 

• Pregnant women who managed to conceive spontaneously or by Assisted Reproduction treatment.
• Women of advanced maternal age (over 35 years old), who have a higher risk of presenting a chromosomal abnormality.
• Women who wish to know the sex of their baby(s) from the 10th week of pregnancy.

Patients coming from an Assisted Reproduction treatment who did not undergo a Preimplantation Genetic Test for aneuploidy (PGT-A).

Choose the modality that suits you best!

If you have any questions about the Clarix or are considering choosing this test to feel much more confident about your health and your baby's health, schedule an appointment with our Maternal-Fetal specialists who will show you the best way forward.